[go: up one dir, main page]

IT1291930B1 - Composizione riequilibratrice delle turbe dell'umore in individui sani - Google Patents

Composizione riequilibratrice delle turbe dell'umore in individui sani

Info

Publication number
IT1291930B1
IT1291930B1 IT97RM000365A ITRM970365A IT1291930B1 IT 1291930 B1 IT1291930 B1 IT 1291930B1 IT 97RM000365 A IT97RM000365 A IT 97RM000365A IT RM970365 A ITRM970365 A IT RM970365A IT 1291930 B1 IT1291930 B1 IT 1291930B1
Authority
IT
Italy
Prior art keywords
mood
healthy individuals
balancing composition
turn
turn balancing
Prior art date
Application number
IT97RM000365A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM970365A0 publication Critical patent/ITRM970365A0/it
Priority to IT97RM000365A priority Critical patent/IT1291930B1/it
Priority to JP50409799A priority patent/JP2002505681A/ja
Priority to DK98929625T priority patent/DK1001760T3/da
Priority to CA002294589A priority patent/CA2294589A1/en
Priority to EP98929625A priority patent/EP1001760B1/en
Priority to KR1019997011909A priority patent/KR20010013887A/ko
Priority to US09/446,358 priority patent/US6335021B1/en
Priority to ES98929625T priority patent/ES2236910T3/es
Priority to PT98929625T priority patent/PT1001760E/pt
Priority to DE69828881T priority patent/DE69828881T2/de
Priority to PCT/IT1998/000157 priority patent/WO1998057629A1/en
Priority to AU79304/98A priority patent/AU7930498A/en
Priority to AT98929625T priority patent/ATE288265T1/de
Publication of ITRM970365A1 publication Critical patent/ITRM970365A1/it
Application granted granted Critical
Publication of IT1291930B1 publication Critical patent/IT1291930B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT97RM000365A 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani IT1291930B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani
US09/446,358 US6335021B1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals
PT98929625T PT1001760E (pt) 1997-06-18 1998-06-12 Composicao para controlar disturbios de humor em individuos saudaveis
CA002294589A CA2294589A1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals
EP98929625A EP1001760B1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals
KR1019997011909A KR20010013887A (ko) 1997-06-18 1998-06-12 건강한 사람의 감정 장애 조절을 위한 조성물
JP50409799A JP2002505681A (ja) 1997-06-18 1998-06-12 健常人における気分障害を調節するための組成物
ES98929625T ES2236910T3 (es) 1997-06-18 1998-06-12 Composicion para controlar trastornos del estado de animo en individuos sanos.
DK98929625T DK1001760T3 (da) 1997-06-18 1998-06-12 Præparat til behandling af sindslidelser hos sunde individer
DE69828881T DE69828881T2 (de) 1997-06-18 1998-06-12 Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen
PCT/IT1998/000157 WO1998057629A1 (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals
AU79304/98A AU7930498A (en) 1997-06-18 1998-06-12 Composition for controlling mood disorders in healthy individuals
AT98929625T ATE288265T1 (de) 1997-06-18 1998-06-12 Zusammensetzung zur linderung von störungen der stimmungslage bei gesunden individuen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani

Publications (3)

Publication Number Publication Date
ITRM970365A0 ITRM970365A0 (it) 1997-06-18
ITRM970365A1 ITRM970365A1 (it) 1998-12-18
IT1291930B1 true IT1291930B1 (it) 1999-01-21

Family

ID=11405131

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97RM000365A IT1291930B1 (it) 1997-06-18 1997-06-18 Composizione riequilibratrice delle turbe dell'umore in individui sani

Country Status (13)

Country Link
US (1) US6335021B1 (it)
EP (1) EP1001760B1 (it)
JP (1) JP2002505681A (it)
KR (1) KR20010013887A (it)
AT (1) ATE288265T1 (it)
AU (1) AU7930498A (it)
CA (1) CA2294589A1 (it)
DE (1) DE69828881T2 (it)
DK (1) DK1001760T3 (it)
ES (1) ES2236910T3 (it)
IT (1) IT1291930B1 (it)
PT (1) PT1001760E (it)
WO (1) WO1998057629A1 (it)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2806307B1 (fr) * 2000-03-20 2002-11-15 Mane Fils V Preparation parfumee solide sous forme de microbilles et utilisation de ladite preparation
AU2002245588A1 (en) * 2001-03-04 2002-09-19 Sterling Medivations, Inc. Infusion hub assembly and fluid line disconnect system
SK15862003A3 (sk) * 2001-05-29 2004-06-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Použitie alkanoyl L-karnitínu na prípravu liečiva na liečenie anhedónie
US7700074B2 (en) * 2002-02-07 2010-04-20 Pettegrew Jay W Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism
US7407778B2 (en) * 2002-02-07 2008-08-05 Pettegrew Jay W Compounds, compositions and methods for treating neuropsychiatric disorders
US20050272812A1 (en) * 2002-02-07 2005-12-08 Pettegrew Jay W Methor for use of acetyl-L-carnitine (ALCAR) for treatment of depressive disorders in humans
US20040071681A1 (en) * 2002-10-10 2004-04-15 Lydia Muller Method and composition for reducing cravings for a craved substance
WO2004110963A2 (en) * 2003-05-29 2004-12-23 Pettegrew Jay W Glycerophosphocholine and its derivatives for medical imaging neuropsychiatric disorders
US20060257842A1 (en) * 2003-05-29 2006-11-16 Pettegrew Jay W Cryopreservation media and molecules
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
JP2006137746A (ja) * 2004-10-13 2006-06-01 Otsuka Pharmaceut Factory Inc オレキシン誘導組成物
US20070015495A1 (en) * 2005-07-15 2007-01-18 Agilis Systems, Inc. Mobile resource location-based customer contact methods
US20080033763A1 (en) * 2005-11-30 2008-02-07 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems related to receiving nutraceutical associated information
US7827042B2 (en) * 2005-11-30 2010-11-02 The Invention Science Fund I, Inc Methods and systems related to transmission of nutraceutical associated information
US20070136092A1 (en) * 2005-11-30 2007-06-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
US7927787B2 (en) * 2006-06-28 2011-04-19 The Invention Science Fund I, Llc Methods and systems for analysis of nutraceutical associated components
US20080114577A1 (en) * 2005-11-30 2008-05-15 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational methods and systems associated with nutraceutical related assays
US8297028B2 (en) 2006-06-14 2012-10-30 The Invention Science Fund I, Llc Individualized pharmaceutical selection and packaging
US7974856B2 (en) 2005-11-30 2011-07-05 The Invention Science Fund I, Llc Computational systems and methods related to nutraceuticals
US8340944B2 (en) * 2005-11-30 2012-12-25 The Invention Science Fund I, Llc Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20070124218A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems related to individualized nutraceutical selection and packaging
US20080052114A1 (en) * 2005-11-30 2008-02-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems and methods related to nutraceuticals
US20080103746A1 (en) * 2005-11-30 2008-05-01 Searete Llc, A Limited Liability Corporation Systems and methods for pathogen detection and response
US20070124176A1 (en) * 2005-11-30 2007-05-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational and/or control systems and methods related to nutraceutical agent selection and dosing
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
US10296720B2 (en) * 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US8000981B2 (en) 2005-11-30 2011-08-16 The Invention Science Fund I, Llc Methods and systems related to receiving nutraceutical associated information
US20070289258A1 (en) * 2006-06-14 2007-12-20 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Individualized pharmaceutical selection and packaging
US20080004905A1 (en) * 2006-06-28 2008-01-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for analysis of nutraceutical associated components
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
CA2801281C (en) 2010-06-16 2018-07-10 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue
CA3172190A1 (en) 2020-05-15 2021-11-18 Alfasigma S.P.A. Composition comprising methylfolate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0340759A1 (en) 1988-05-06 1989-11-08 MAGIS FARMACEUTICI S.p.A. Salts of O-mono (di)-acetyl-glycero-mono-(bis)-(di)-phosphates of L-acetyl-carnitine and of L-acetyl carnitine esters
JP3942207B2 (ja) 1995-02-17 2007-07-11 武田薬品工業株式会社 うつ性症状改善剤
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6066664A (en) * 1997-06-06 2000-05-23 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for decreasing the appetite in bulimic, overweight individuals

Also Published As

Publication number Publication date
CA2294589A1 (en) 1998-12-23
EP1001760B1 (en) 2005-02-02
ITRM970365A1 (it) 1998-12-18
ITRM970365A0 (it) 1997-06-18
KR20010013887A (ko) 2001-02-26
ATE288265T1 (de) 2005-02-15
DE69828881T2 (de) 2006-01-19
AU7930498A (en) 1999-01-04
US6335021B1 (en) 2002-01-01
DK1001760T3 (da) 2005-05-23
WO1998057629A1 (en) 1998-12-23
PT1001760E (pt) 2005-04-29
JP2002505681A (ja) 2002-02-19
ES2236910T3 (es) 2005-07-16
DE69828881D1 (de) 2005-03-10
EP1001760A1 (en) 2000-05-24

Similar Documents

Publication Publication Date Title
IT1291930B1 (it) Composizione riequilibratrice delle turbe dell'umore in individui sani
NO972972L (no) Sammensetninger for behandling av dermatologiske forstyrrelser og metoder for deres anvendelse
EP0902665A4 (en) NUTRITIONAL PHYTO-ESTROGENES IN ESTRO-REPLACEMENT THERAPY
DE60133389D1 (de) Gabapentinanaloga für schlafstörungen
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
IT1284108B1 (it) Presidio chirurgico per il trattamento dell'enfisema polmonare
EP1252329A4 (en) HYPOKRETIN AND HYPOKRETINRECEPTORS FOR THE REGULATION OF SLEEP AND RELATED DISORDERS
IT1281749B1 (it) Compressore con struttura perfezionata dell'unita' valvolare
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
EE03953B1 (et) 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks
NO20000771L (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
ITVE960028A0 (it) Dispositivo di regolazione dell'altezza della spalliera dello schienale in particolare in sedie da ufficio.
PT1124556E (pt) Utilizacao de (r)-tofisopam opticamente puro para tratamento e prevencao de perturbacoes da ansiedade e sua composicao
CA2260863A1 (en) Treatment of psychotic disorders
BR9909868A (pt) Ascorbato de paroxetina
ITMI941939A0 (it) Derivati purinici ed 8-azapurinici atti al trattamento terapeutico dell'aids
AU5255501A (en) Choline derivatives for the treatment of alzheimer's disease
EP0893497A4 (en) NEW OXIDOREDUCTASE AND THE USE THEREOF IN A METHOD FOR PRODUCING 3- (P-HYDROXYPHENYL) -2-PROPENOL DERIVATIVES AND OTHER COMPOUNDS
NO984430D0 (no) Anvendelse av en inhibitor av Na+/H+-utveksler for fremstilling av medikament for behandling av profylakser av sykdommer i sentralnervesystemet
ITMI930736A0 (it) Derivato espossidico dell'eparano solfato
IT1282904B1 (it) Macchinario per l'esercizio dei muscoli facciali e per il miglioramento dell'aspetto estetico del viso
IT1286908B1 (it) Dispositivo automatico per regolarizzare l'adagiamento delle maglie sul piano di impilatura
IT1227936B (it) Apparecchio per l'aerosolterapia delle alterazioni patologiche ed estetiche dell'occhio e suoi annessi
ITCO980008A0 (it) Cinematiamo per l'allungamento di un piano mediante rotazione ed inalzamento della prolunga a scomparsa sottopiano
ITMI941036A0 (it) Impiego dell'epilattosio nel trattamento dei tumori e delle malattie autoimmuni

Legal Events

Date Code Title Description
0001 Granted